TRANSPEK INDUSTRY LTD.-$ - 506687 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates and Stop Transfer20-03-2023
20-03-2023
TRANSPEK INDUSTRY LTD.-$ - 506687 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of original share certificates and subsequent issue of duplicate share certificates under Regulation 39(3) of the SEBI (LODR), Regulations, 2015.14-03-2023
TRANSPEK INDUSTRY LTD.-$ - 506687 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates and Stop Transfer06-03-2023
TRANSPEK INDUSTRY LTD.-$ - 506687 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the Investor Call held on 17/02/2023.21-02-2023
TRANSPEK INDUSTRY LTD.-$ - 506687 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of the Investor Call available on website of the Company viz. www.transpek.com.17-02-2023
TRANSPEK INDUSTRY LTD.-$ - 506687 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Duplicate Share Certificates and Stop Transfer16-02-2023
TRANSPEK INDUSTRY LTD.-$ - 506687 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for Q3 and 9M Results for the Financial Year 2022-2023.15-02-2023
TRANSPEK INDUSTRY LTD.-$ - 506687 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Conference Call to be held on Friday, 17/02/2023 at 04.00 p.m.14-02-2023
TRANSPEK INDUSTRY LTD.-$ - 506687 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 08/02/2023.
Unaudited (Standalone and Consolidated) Results for the quarter ended 31/12/2022.08-02-2023
TRANSPEK INDUSTRY LTD.-$ - 506687 - Board Meeting Intimation for Unaudited Results
TRANSPEK INDUSTRY LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 ,inter alia, to consider and approve Considering and Approval of Unaudited Results (Standalone and Consolidated) For the quarter ended 31st December, 2022.31-01-2023